Amplifica Makes SCUBE3 Official
January 27, 2023
The incoming news of the hair growth/loss treatment industry seems to be rolling in at an all-time high these days. Just two weeks after announcing their collaboration with UK biotech Ingenza, Amplifica has issued another press release announcing that they have officially added SCUBE3 to their development pipeline. In order to do so, Amplifica signed a license agreement with the University of California, where the original hair follicle signaling research took place. The SCUBE3 product will be labeled as AMP-601 in the company’s pipeline.